...
首页> 外文期刊>Journal of the American Pharmacists Association: JAPhA >Once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in liver transplantation
【24h】

Once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in liver transplantation

机译:每日延长释放的Tacrolimus与肝移植中的两次巨饰血症

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: For patients who have received a kidney transplant, studies have shown that once-daily prolonged-release tacrolimus (TAC) has similar efficacy and safety to standard twice-daily dosing. The purpose of this study was to perform a meta-analysis to compare the effectiveness and safety of daily TAC (TAC qd) versus standard twice-daily TAC (TAC bid) administration in liver transplantation (LT).
机译:目的:对于接受肾移植的患者,研究表明,每日延长释放的Tacrolimus(TAC)对标准的两次给药有类似的疗效和安全性。 本研究的目的是进行META分析,以比较日常TAC(TAC QD)与标准两次每日TAC(TAC BID)给药在肝移植(LT)中的疗效的有效性和安全性。

著录项

  • 来源
  • 作者单位

    Sun Yat Sen Univ Affiliated Hosp 1 Organ Transplant Ctr 58 Zhongshan 2nd Rd Guangzhou 510080;

    Sun Yat Sen Univ Affiliated Hosp 1 Organ Transplant Ctr 58 Zhongshan 2nd Rd Guangzhou 510080;

    Guangzhou Med Univ Peoples Hosp 1 Dept Resp Guangzhou Guangdong Peoples R China;

    Duke Univ Med Ctr Dept Surg Durham NC 27710 USA;

    Sun Yat Sen Univ Affiliated Hosp 1 Organ Transplant Ctr 58 Zhongshan 2nd Rd Guangzhou 510080;

    Sun Yat Sen Univ Affiliated Hosp 1 Organ Transplant Ctr 58 Zhongshan 2nd Rd Guangzhou 510080;

    Sun Yat Sen Univ Affiliated Hosp 1 Organ Transplant Ctr 58 Zhongshan 2nd Rd Guangzhou 510080;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号